TSART TRIO 12.5MG (Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg))

Tsart Trio 12.5 mg Tablet is formulated as a combination therapy for managing hypertension, particularly in cases where monotherapy does not yield adequate control of blood pressure. By effectively lowering elevated blood pressure levels, this medication can significantly minimize the risk of cardiovascular events such as heart attacks and strokes. It is crucial to take Tsart Trio with food to enhance its absorption and efficacy. The prescribed dosage may vary based on individual health conditions and the patient’s response to the medication. For optimal results, it is advisable to administer the tablet at the same time daily and to continue usage as directed by the healthcare provider, even in the absence of noticeable symptoms. Since hypertension often presents without overt symptoms, discontinuing the medication prematurely could elevate the risk of severe cardiovascular complications. This tablet contains a diuretic component, which may increase urination; therefore, it is recommended to avoid dosing within four hours of bedtime to minimize nocturnal bathroom visits. Staying well-hydrated while using this medication can help mitigate potential side effects such as muscle weakness, dry mouth, and excessive thirst. It is important to disclose any pre-existing liver or kidney issues to your physician prior to starting this medication. Regular monitoring of blood pressure, renal function, electrolyte balance, and blood glucose levels is advised to ensure the treatment’s effectiveness and safety.